BCX-34 topical small molecule inhibitor of purine nucleoside phosphorylase: Began Phase III trial in 90 patients, with end points of complete and partial remiss

BioCryst Pharmaceuticals Inc. (BCRX), Birmingham, Ala. Product: BCX-34 topical small molecule inhibitor of purine nucleoside phosphorylase, an enzyme that directs T cells to proliferate Indication: E...